Medtronic hits regulatory milestone for TAVI devices

05/24/2013 | Medical Device & Diagnostic Industry online

Medtronic has obtained CE mark approval in Europe for its CoreValve and CoreValve Evolut transcatheter aortic valve implantation devices to be used in valve-in-valve procedures, which are meant to replace degenerated surgical aortic valves in patients who are at high risk for open-heart surgery. The CoreValve TAVI device is still undergoing clinical studies in the U.S.

View Full Article in:

Medical Device & Diagnostic Industry online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA